Anti-Hypertensive Drugs Global Market Report 2024

Global Anti-Hypertensive Drugs Market Report 2024

Anti-Hypertensive Drugs Global Market Report 2024 – By Therapeutics (Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators), By Disease Source (Primary Hypertension, Secondary Hypertension), By End Users (Hospitals, Clinics, Homecare) – Market Size, Trends, And Global Forecast 2024-2033

Name: Anti-Hypertensive Drugs Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Anti-Hypertensive Drugs Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Anti-Hypertensive Drugs Global Market Report 2024

Proud Members Of

Anti-Hypertensive Drugs Market Definition

Anti-hypertensive drugs refer to a group of medications used to treat high blood pressure (high blood pressure). The goal of antihypertensive therapy is to prevent the negative effects of high blood pressure, such as myocardial infarction and stroke.

The main therapeutics of anti-hypertensive drugs are diuretics, angiotensin receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, alpha-blockers, calcium channel blockers, renin inhibitors, and vasodilators. Diuretics, also known as water pills, are medications that increase the amount of water and salt excreted by the body in the form of urine. The various sources of diseases include primary hypertension and secondary hypertension, which are treated in hospitals, clinics, and at home care.

Anti-Hypertensive Drugs Market Segmentation

The anti-hypertensive drugs market covered in this report is segmented –

1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators

2) By Disease Source: Primary Hypertension, Secondary Hypertension

3) By End Users: Hospitals, Clinics, Homecare

Global Anti-Hypertensive Drugs Market Size 2023 to 2028: Graph

Anti-Hypertensive Drugs Market Size 2024 And Growth Rate

The anti-hypertensive drugs market size has grown steadily in recent years. It will grow from $35.8 billion in 2023 to $36.7 billion in 2024 at a compound annual growth rate (CAGR) of 2.5%. The growth in the historic period can be attributed to environmental and lifestyle influences, historical market competition, historical treatment preferences, economic conditions, historical global health trends.

Anti-Hypertensive Drugs Market Growth Forecast

The anti-hypertensive drugs market size is expected to see steady growth in the next few years. It will grow to $40.28 billion in 2028 at a compound annual growth rate (CAGR) of 2.4%. The growth in the forecast period can be attributed to cost-effectiveness and affordability, emerging therapeutic innovations, epidemiological trends, regulatory changes and approvals, aging population dynamics, healthcare policies and reimbursement changes. Major trends in the forecast period include therapeutic innovation, epidemiological shifts, regulatory landscape, healthcare policies, advancements in diagnosis and monitoring.

Book your 30 minutes free consultation with our research experts

Anti-Hypertensive Drugs Market Driver: Sedentary Lifestyle And The Rising Demand For Anti-Hypertensive Drugs

A sedentary lifestyle is a major driver of the growth of the anti-hypertensive drug market. Consumption of junk food, lack of proper healthy and balanced diet, and lack of proper sleep due to irregular work shifts have contributed to the increase in hypertension. Hypertension is the underlying factor for at least 45% of deaths due to heart disease and 51% of deaths due to stroke. Once the patient is diagnosed with hypertension, patients are required to use the drugs to control hypertension based on the severity of the condition. Furthermore, in June 2021, according to the World Health Organization data 2021, a Switzerland-based Government agency responsible for international public health, cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. This creates a sustainable demand for the product and acts as a prominent driver for the growth of the market.

Anti-Hypertensive Drugs Market Driver: Increasing Prevalence Of Cardiovascular Diseases In The Anti-Hypertensive Drugs Market

The increasing prevalence of cardiovascular diseases is anticipated to propel the growth of the anti-hypertensive drugs market going forward. Cardiovascular diseases (CVDs) refer to a class of diseases that affect the heart and blood vessels which are associated with risk factors such as smoking, high blood pressure, high cholesterol, diabetes, obesity, and a sedentary lifestyle. Anti-hypertensive drugs are used to manage and reduce high blood pressure, which is a major risk factor for cardiovascular diseases (CVDs) among older adults and these medications aim to reduce the risk of this disease. For instance, in October 2022, according to the National Library of Medicine, a US-based federal agency, by 2035, 45.1% of the US population is projected to have cardiovascular disease. The total costs of cardiovascular diseases are expected to reach $1.1 trillion in 2035. Additionally, in May 2023, according to the World Heart Federation (WHF), a Switzerland-based non-governmental organization, there was 20.5 million deaths from cardiovascular diseases in 2021. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the anti-hypertensive drugs market.

Global Anti-Hypertensive Drugs Market Major Players

Major companies operating in the anti-hypertensive drugs market report are Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbiVe Inc., Bayer AG, Novartis AG, Sanofi SA, Astra Zeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., C.H. Boehringer Sohn AG & Ko. KG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Fresenius Kabi AG, Sun Pharmaceuticals LLC, Cipla Limited, Dr. Reddy's Laboratories, Hikma Pharmaceuticals PLC, Lupin Limited, United Therapeutics, Torrent Pharmaceuticals Ltd, Ranbaxy Laboratories, Noden Pharma DAC, Acacia Pharma Group Plc, Actelion Pharmaceuticals Ltd.

Global Anti-Hypertensive Drugs Market Restraint: Challenges In The Anti-Hypertensive Drugs Market

Low awareness of the antihypertensive drugs amongst the population is one of the major restraints in the anti-hypertensive drugs market. Firstly, most people in developing nations neglect their health checkups and are not aware of their existing hypertension condition in them until they detect extreme symptoms. Secondly, persons diagnosed with hypertension are not adherent to their medication schedule and stop taking medication after 1-2 weeks until symptoms return, thereby posing a huge challenge to the anti-hypertensive drugs market. For example, BMC Research notes published a research survey (from a developing country) which states that out of the total 112 hypertensive subjects with stroke, only 17% of them were adherent to antihypertensive medications. Thus, lack of awareness and low drug adherence restraint the growth of the antihypertensive market.

Global Anti-Hypertensive Drugs Market Trend: Innovative Advancements In The Anti-Hypertensive Drugs Market

Major companies operating in the anti-hypertensive drugs market are focusing on innovating new products, such as Metoprolol Succinate Extended-Release Tablets, to provide a competitive edge in the market. Metoprolol Succinate Extended-Release Tablets are used as anti-hypertensive drugs for patients with hypertension. For instance, in June 2023, Granules India Limited, an Indian-based pharmaceutical manufacturing company, launched Metoprolol Succinate Extended-Release Tablets approved by the Food and Drug Administration (FDA), a US-based federal agency. Metoprolol Succinate Extended-Release Tablets are anti-hypertensive drugs designed for the treatment of hypertension in order to lower blood pressure. These tablets are available in varying strengths, including 25mg, 50mg, 100mg, and 200mg. This consists of beta-blockers that slow down the heart rate, reduce the workload on the heart, and lower blood pressure.

Global Anti-Hypertensive Drugs Market Trend: Efficacy And Acceptance Of Combination Therapy Over Monotherapy In The Anti-Hypertensive Drugs Market

Of late, there has been a rise in the use of combination therapies compared to monotherapy treatment. Monotherapy is the treatment of hypertension with a single drug, while the use of combinations of drugs (Combination Therapy) allows for action on several different hypertensive mechanisms. When the two drugs are combined with different mechanisms of action, the effect is two to five times greater than monotherapy. Increasing the dose of monotherapy reduces coronary events by 29% and cerebrovascular events by 40%, while combining two antihypertensive agents with a different mechanism of action reduces coronary events by 40% and cerebrovascular events by 54%. Thus, the use of combination therapy provides greater protection to a target organ than increasing the dose of monotherapy. The trend of using combination therapy is thus more effective and is being widely accepted as well.

Anti-Hypertensive Drugs Market Merger And Acquisition:

US Food And Drug Administration (FDA) Guidelines For Fixed-Combination Drugs In The Anti-Hypertensive Drugs Market

The US Food and Drug Administration (FDA) issued guidance on developing fixed-combination drugs to treat hypertension. This primarily focuses on the clinical development of two-drug combinations of previously approved products. The US FDA expects to see a reduction in adverse effects for combinations that include doses below each drug’s maximum dose compared to single drug regimens at their maximum dose. Earlier physicians typically started a patient on a single drug and titrated up to a maximum dose before adding additional drugs to their program, current guidelines recommend starting patients on two drugs at less than their full doses. Hence, this guidance would keep a check on fixed-combination drugs.

Regional Insights For The Global Anti-Hypertensive Drugs Market

North America was the largest region in the anti-hypertensive drugs market in 2023. The Middle East is expected to be the largest growing region in the global anti-hypertensive drugs market during the forecast period. The regions covered in the anti-hypertensive drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anti-hypertensive drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The anti-hypertensive drugs market consists of sales of thiazide-type diuretics, beta-blocker metoprolol, olmesartan, and HCTZ. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The anti-hypertensive drugs market research report is one of a series of new reports from The Business Research Company that provides anti-hypertensive drugs market statistics, including anti-hypertensive drugs industry global market size, regional shares, competitors with an anti-hypertensive drugs market share, detailed anti-hypertensive drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anti-hypertensive drugs industry. This anti-hypertensive drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Anti-Hypertensive Drugs Market Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$36.7 billion
Revenue Forecast In 2033	$40.28 billion
Growth Rate	CAGR of 2.4% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators 2) By Disease Source: Primary Hypertension, Secondary Hypertension 3) By End Users: Hospitals, Clinics, Homecare
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc.; Johnson & Johnson Ltd.; F. Hoffmann-La Roche Ltd; Merck & Co. Inc.; AbbiVe Inc.; Bayer AG; Novartis AG; Sanofi SA; Astra Zeneca plc; Abbott Laboratories; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Gilead Sciences Inc.; C.H. Boehringer Sohn AG & Ko. KG; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Daiichi Sankyo Company Limited; Fresenius Kabi AG; Sun Pharmaceuticals LLC; Cipla Limited; Dr. Reddy's Laboratories; Hikma Pharmaceuticals PLC; Lupin Limited; United Therapeutics; Torrent Pharmaceuticals Ltd; Ranbaxy Laboratories; Noden Pharma DAC; Acacia Pharma Group Plc; Actelion Pharmaceuticals Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Anti-Hypertensive Drugs Market Characteristics

3. Anti-Hypertensive Drugs Market Trends And Strategies

4. Anti-Hypertensive Drugs Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Anti-Hypertensive Drugs Market Size and Growth

5.1. Global Anti-Hypertensive Drugs Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Anti-Hypertensive Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Anti-Hypertensive Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Anti-Hypertensive Drugs Market Segmentation

6.1. Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Diuretics

Angiotensin Receptor Blockers (ARBs)

Angiotensin Converting Enzyme (ACE) Inhibitors

Beta Blockers

Alpha Blockers

Calcium Channel Blockers

Renin Inhibitors

Vasodilators

6.2. Global Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Primary Hypertension

Secondary Hypertension

6.3. Global Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals

Clinics

Homecare

7. Anti-Hypertensive Drugs Market Regional And Country Analysis

7.1. Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Anti-Hypertensive Drugs Market

8.1. Asia-Pacific Anti-Hypertensive Drugs Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Anti-Hypertensive Drugs Market

9.1. China Anti-Hypertensive Drugs Market Overview

9.2. China Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Anti-Hypertensive Drugs Market

10.1. India Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Anti-Hypertensive Drugs Market

11.1. Japan Anti-Hypertensive Drugs Market Overview

11.2. Japan Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Anti-Hypertensive Drugs Market

12.1. Australia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Anti-Hypertensive Drugs Market

13.1. Indonesia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Anti-Hypertensive Drugs Market

14.1. South Korea Anti-Hypertensive Drugs Market Overview

14.2. South Korea Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Anti-Hypertensive Drugs Market

15.1. Western Europe Anti-Hypertensive Drugs Market Overview

15.2. Western Europe Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Anti-Hypertensive Drugs Market

16.1. UK Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Anti-Hypertensive Drugs Market

17.1. Germany Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Anti-Hypertensive Drugs Market

18.1. France Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Anti-Hypertensive Drugs Market

19.1. Italy Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Anti-Hypertensive Drugs Market

20.1. Spain Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Anti-Hypertensive Drugs Market

21.1. Eastern Europe Anti-Hypertensive Drugs Market Overview

21.2. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Anti-Hypertensive Drugs Market

22.1. Russia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Anti-Hypertensive Drugs Market

23.1. North America Anti-Hypertensive Drugs Market Overview

23.2. North America Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Anti-Hypertensive Drugs Market

24.1. USA Anti-Hypertensive Drugs Market Overview

24.2. USA Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Anti-Hypertensive Drugs Market

25.1. Canada Anti-Hypertensive Drugs Market Overview

25.2. Canada Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Anti-Hypertensive Drugs Market

26.1. South America Anti-Hypertensive Drugs Market Overview

26.2. South America Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Anti-Hypertensive Drugs Market

27.1. Brazil Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Anti-Hypertensive Drugs Market

28.1. Middle East Anti-Hypertensive Drugs Market Overview

28.2. Middle East Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Anti-Hypertensive Drugs Market

29.1. Africa Anti-Hypertensive Drugs Market Overview

29.2. Africa Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Anti-Hypertensive Drugs Market Competitive Landscape And Company Profiles

30.1. Anti-Hypertensive Drugs Market Competitive Landscape

30.2. Anti-Hypertensive Drugs Market Company Profiles

30.2.1. Pfizer Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Johnson & Johnson Ltd.

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. F. Hoffmann-La Roche Ltd

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Merck & Co. Inc.

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. AbbiVe Inc.

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Anti-Hypertensive Drugs Market Other Major And Innovative Companies

31.1. Bayer AG

31.2. Novartis AG

31.3. Sanofi SA

31.4. Astra Zeneca plc

31.5. Abbott Laboratories

31.6. GlaxoSmithKline plc

31.7. Takeda Pharmaceutical Company Limited

31.8. Eli Lilly and Company

31.9. Gilead Sciences Inc.

31.10. C.H. Boehringer Sohn AG & Ko. KG

31.11. Teva Pharmaceutical Industries Ltd.

31.12. Mylan N.V.

31.13. Daiichi Sankyo Company Limited

31.14. Fresenius Kabi AG

31.15. Sun Pharmaceuticals LLC

32. Global Anti-Hypertensive Drugs Market Competitive Benchmarking

33. Global Anti-Hypertensive Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Anti-Hypertensive Drugs Market

35. Anti-Hypertensive Drugs Market Future Outlook and Potential Analysis

35.1 Anti-Hypertensive Drugs Market In 2028 - Countries Offering Most New Opportunities

35.2 Anti-Hypertensive Drugs Market In 2028 - Segments Offering Most New Opportunities

35.3 Anti-Hypertensive Drugs Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: China, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: India, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: Japan, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Australia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Indonesia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: South Korea, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: Western Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: UK, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: Germany, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: France, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: Italy, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Spain, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Russia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: North America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: USA, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: Canada, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: South America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: Brazil, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Middle East, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Africa, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Pfizer Inc. Financial Performance

Table 75: Johnson & Johnson Ltd. Financial Performance

Table 76: F. Hoffmann-La Roche Ltd Financial Performance

Table 77: Merck & Co. Inc. Financial Performance

Table 78: AbbVie Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: China, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: India, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: Japan, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Australia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Indonesia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: South Korea, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: Western Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: UK, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: Germany, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: France, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: Italy, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Spain, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Russia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: North America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: USA, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: Canada, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: South America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: Brazil, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Middle East, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Africa, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Anti-Hypertensive Drugs Market, Segmentation By Disease Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Anti-Hypertensive Drugs Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Pfizer Inc. Financial Performance

Figure 75: Johnson & Johnson Ltd. Financial Performance

Figure 76: F. Hoffmann-La Roche Ltd Financial Performance

Figure 77: Merck & Co. Inc. Financial Performance

Figure 78: AbbVie Inc. Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the high potency apis market research report 2022 with industry size, share, segments and market growth

Drugs for Immunotherapy Global Market Report 2024 – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Immunoglobulins Global Market Report 2024 – By Product (IGG, IGA, IGM, IGE, IGD. ), By Mode Of Delivery (Intravenous Mode of Delivery, Subcutaneous Mode of Delivery), By Application (Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pharmaceutical Glass Packaging Global Market Report 2024 – By Product (Ampoules, Bottles , Vials, Syringes, Cartridges, Other Product Types), By Drug Type (Generic, Branded, Biologic), By Material (Type I, Type II, Type III), By Application (Oral, Injectable, Nasal, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cellular Immunotherapy Global Market Report 2024 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Immunosuppressants Global Market Report 2024 – By Drug Class (Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Other Drug Classes), By Indication (Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Drugs For Hormonal Replacement Therapy Global Market Report 2024 – By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Menopause, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Hormonal Contraceptives Global Market Report 2024 – By Product (Pills, Injectable Birth Control, Vaginal Rings, Others), By End User (Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers), By Hormones (Progestin-Only, Combined Hormones), By Distribution Channel (Drug Stores, Gynecology/ Fertility Clinics, E-Commerce, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pharmaceuticals Global Market Report 2022 – By Type (Pharmaceutical Drugs, Biologics), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, E-Commerce), By Nature (Organic, Conventional) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Frequently Asked Questions

What is the definition of the anti-hypertensive drugs market?

How will the anti-hypertensive drugs market drivers and restraints affect the anti-hypertensive drugs market dynamics? What forces will shape the anti-hypertensive drugs industry going forward?

The anti-hypertensive drugs market major growth driver - sedentary lifestyle and the rising demand for anti-hypertensive drugs. For further insights on the anti-hypertensive drugs market, request a sample here

What is the forecast market size or the forecast market value of the anti-hypertensive drugs market ?

The anti-hypertensive drugs market size has grown steadily in recent years. It will grow from $35.8 billion in 2023 to $36.7 billion in 2024 at a compound annual growth rate (CAGR) of 2.5%. The growth in the historic period can be attributed to environmental and lifestyle influences, historical market competition, historical treatment preferences, economic conditions, historical global health trends. The anti-hypertensive drugs market size is expected to see steady growth in the next few years. It will grow to $40.28 billion in 2028 at a compound annual growth rate (CAGR) of 2.4%. The growth in the forecast period can be attributed to cost-effectiveness and affordability, emerging therapeutic innovations, epidemiological trends, regulatory changes and approvals, aging population dynamics, healthcare policies and reimbursement changes. Major trends in the forecast period include therapeutic innovation, epidemiological shifts, regulatory landscape, healthcare policies, advancements in diagnosis and monitoring. For further insights on the anti-hypertensive drugs market, request a sample here

How is the anti-hypertensive drugs market segmented?

The anti-hypertensive drugs market is segmented
1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators
2) By Disease Source: Primary Hypertension, Secondary Hypertension
3) By End Users: Hospitals, Clinics, HomecareFor further insights on the anti-hypertensive drugs market, request a sample here

Which region has the largest share of the anti-hypertensive drugs market? What are the other regions covered in the report?

North America was the largest region in the anti-hypertensive drugs market in 2023. The Middle East is expected to be the largest growing region in the global anti-hypertensive drugs market during the forecast period. The regions covered in the anti-hypertensive drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the anti-hypertensive drugs market, request a sample here.

Who are the major players in the anti-hypertensive drugs market?

What are the key trends in the anti-hypertensive drugs market?

Major trend in the anti-hypertensive drugs market - innovative advancements in the anti-hypertensive drugs market. For further insights on the anti-hypertensive drugs market, request a sample here.

What are the major opportunities in the anti-hypertensive drugs market? What are the strategies for the anti-hypertensive drugs market?

For detailed insights on the major opportunities and strategies in the anti-hypertensive drugs market, request a sample here.

How does the anti-hypertensive drugs market relate to the overall economy and other similar markets?

For detailed insights on anti-hypertensive drugs market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the anti-hypertensive drugs industry?

For detailed insights on the mergers and acquisitions in the anti-hypertensive drugs industry, request a sample here.

What are the key dynamics influencing the anti-hypertensive drugs market growth? SWOT analysis of the anti-hypertensive drugs market.

For detailed insights on the key dynamics influencing the anti-hypertensive drugs market growth and SWOT analysis of the anti-hypertensive drugs industry, request a sample here.